Abstract

This publication is devoted to the tactics of management of patients with atrial fibrillation during the pandemic of new coronavirus infection (COVID-19). Among the key issues of relevance during this period, we thought it possible to consider the epidemiology, prevalence, and pathophysiological mechanisms of atrial fibrillation in patients with COVID-19, as well as treatment strategies with regard to obvious hospitalization, rhythm control/restoration and prevention of thromboembolic events. A separate issue is the tactics regarding the prescription or continuation of therapy aimed at the prevention of thromboembolic events and possible drug interactions in patients treated for COVID-19 and receiving anticoagulant therapy with direct oral anticoagulants for atrial fibrillation. Keywords: atrial fibrillation, COVID-19, thromboembolic events, anticoagulant therapy For citation: Napalkov DA, Sokolova AA, Skripka AI. Features of the management of patients with atrial fibrillation during the COVID-19 pandemic: current questions and possible answers, Consilium Medicum. 2021; 23 (1): 32–34. DOI: 10.26442/20751753.2021.1.200669

Highlights

  • В публикациях из Китая, относящихся к начальным этапам пандемии, было отмечено выявление клинически значимых аритмий у 17% пациентов, госпитализированных с COVID-19

  • This publication is devoted to the tactics of management

  • the tactics regarding the prescription or continuation of therapy aimed at the prevention of thromboembolic events

Read more

Summary

Introduction

В публикациях из Китая, относящихся к начальным этапам пандемии, было отмечено выявление клинически значимых аритмий у 17% пациентов, госпитализированных с COVID-19. Как часто развиваются разные виды аритмий у пациентов, госпитализированных по поводу covid-19? Какова встречаемость Фп у пациентов, госпитализированных по поводу covid-19? На основании имеющихся данных можно говорить о том, что ФП встречается у 19–21% госпитализированных по поводу COVID-19 пациентов [3, 4].

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call